 | • レポートコード：MRC308GR10657 • 出版社/出版日：GlobalInfoResearch / 2023年8月14日 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（2-3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
GlobalInfoResearchの最新の調査によると、世界のラパマイシン標的溶出ステント装置の市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界のラパマイシン標的溶出ステント装置市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、種類別、用途別に記載されています。
市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。
本レポートの主な目的は次のとおりです。
– 世界および主要国の市場機会の規模を決定するため
– ラパマイシン標的溶出ステント装置の成長可能性を評価するため
– 各製品および最終用途市場の将来の成長を予測するため
– 市場に影響を与える競争要因を評価するため
ラパマイシン標的溶出ステント装置市場は種類と用途によって区分されます。2018年～2029年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。
種類別セグメント
・椎骨動脈ラパマイシン標的溶出ステント装置、冠動脈ラパマイシン標的溶出ステント装置
用途別セグメント
・病院、外来手術センター、その他
主要な市場プレーヤー
・Terumo、QualiMe、Concept Medical、USM Healthcare、Qmedics AG、Cardionovum、MicroPort Scientific、Lepu Medical Technology、Medfavour Medical、Shandong Huaan Biotechnology、Shanghai Bioheart Biological Technology、JW Medical Systems
地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）
本調査レポートの内容は計15章あります。
・第1章では、ラパマイシン標的溶出ステント装置製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要なラパマイシン標的溶出ステント装置メーカーの企業概要、2019年～2022年までのラパマイシン標的溶出ステント装置の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要なラパマイシン標的溶出ステント装置メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別ラパマイシン標的溶出ステント装置の販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までのラパマイシン標的溶出ステント装置の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域でのラパマイシン標的溶出ステント装置市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、およびラパマイシン標的溶出ステント装置の産業チェーンを掲載しています。
・第14、15章では、ラパマイシン標的溶出ステント装置の販売チャネル、販売業者、顧客、調査結果について説明します。
***** 目次(一部) *****
・市場概要
– ラパマイシン標的溶出ステント装置の概要
– 種類別分析（2018年vs2022年vs2029年）：椎骨動脈ラパマイシン標的溶出ステント装置、冠動脈ラパマイシン標的溶出ステント装置
– 用途別分析（2018年vs2022年vs2029年）：病院、外来手術センター、その他
– 世界のラパマイシン標的溶出ステント装置市場規模・予測
– 世界のラパマイシン標的溶出ステント装置生産能力分析
– 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
– Terumo、QualiMe、Concept Medical、USM Healthcare、Qmedics AG、Cardionovum、MicroPort Scientific、Lepu Medical Technology、Medfavour Medical、Shandong Huaan Biotechnology、Shanghai Bioheart Biological Technology、JW Medical Systems
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・種類別分析2018年-2029年：椎骨動脈ラパマイシン標的溶出ステント装置、冠動脈ラパマイシン標的溶出ステント装置
・用途別分析2018年-2029年：病院、外来手術センター、その他
・ラパマイシン標的溶出ステント装置の北米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：アメリカ、カナダ、メキシコなど
・ラパマイシン標的溶出ステント装置のヨーロッパ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・ラパマイシン標的溶出ステント装置のアジア市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・ラパマイシン標的溶出ステント装置の南米市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：ブラジル、アルゼンチンなど
・ラパマイシン標的溶出ステント装置の中東・アフリカ市場
– 種類別市場規模2018年-2029年
– 用途別市場規模2018年-2029年
– 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論
1 Market Overview
1.1 Product Overview and Scope of Rapamycin Target Eluting Stent System
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Rapamycin Target Eluting Stent System Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Vertebral Artery Rapamycin Targeted Elution Stent System
1.3.3 Coronary Rapamycin-Targeted Elution Stenting System
1.4 Market Analysis by Application
1.4.1 Overview: Global Rapamycin Target Eluting Stent System Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Ambulatory Surgery Center
1.4.4 Others
1.5 Global Rapamycin Target Eluting Stent System Market Size & Forecast
1.5.1 Global Rapamycin Target Eluting Stent System Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Rapamycin Target Eluting Stent System Sales Quantity (2018-2029)
1.5.3 Global Rapamycin Target Eluting Stent System Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Terumo
2.1.1 Terumo Details
2.1.2 Terumo Major Business
2.1.3 Terumo Rapamycin Target Eluting Stent System Product and Services
2.1.4 Terumo Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Terumo Recent Developments/Updates
2.2 QualiMe
2.2.1 QualiMe Details
2.2.2 QualiMe Major Business
2.2.3 QualiMe Rapamycin Target Eluting Stent System Product and Services
2.2.4 QualiMe Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 QualiMe Recent Developments/Updates
2.3 Concept Medical
2.3.1 Concept Medical Details
2.3.2 Concept Medical Major Business
2.3.3 Concept Medical Rapamycin Target Eluting Stent System Product and Services
2.3.4 Concept Medical Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Concept Medical Recent Developments/Updates
2.4 USM Healthcare
2.4.1 USM Healthcare Details
2.4.2 USM Healthcare Major Business
2.4.3 USM Healthcare Rapamycin Target Eluting Stent System Product and Services
2.4.4 USM Healthcare Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 USM Healthcare Recent Developments/Updates
2.5 Qmedics AG
2.5.1 Qmedics AG Details
2.5.2 Qmedics AG Major Business
2.5.3 Qmedics AG Rapamycin Target Eluting Stent System Product and Services
2.5.4 Qmedics AG Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Qmedics AG Recent Developments/Updates
2.6 Cardionovum
2.6.1 Cardionovum Details
2.6.2 Cardionovum Major Business
2.6.3 Cardionovum Rapamycin Target Eluting Stent System Product and Services
2.6.4 Cardionovum Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Cardionovum Recent Developments/Updates
2.7 MicroPort Scientific
2.7.1 MicroPort Scientific Details
2.7.2 MicroPort Scientific Major Business
2.7.3 MicroPort Scientific Rapamycin Target Eluting Stent System Product and Services
2.7.4 MicroPort Scientific Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 MicroPort Scientific Recent Developments/Updates
2.8 Lepu Medical Technology
2.8.1 Lepu Medical Technology Details
2.8.2 Lepu Medical Technology Major Business
2.8.3 Lepu Medical Technology Rapamycin Target Eluting Stent System Product and Services
2.8.4 Lepu Medical Technology Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Lepu Medical Technology Recent Developments/Updates
2.9 Medfavour Medical
2.9.1 Medfavour Medical Details
2.9.2 Medfavour Medical Major Business
2.9.3 Medfavour Medical Rapamycin Target Eluting Stent System Product and Services
2.9.4 Medfavour Medical Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Medfavour Medical Recent Developments/Updates
2.10 Shandong Huaan Biotechnology
2.10.1 Shandong Huaan Biotechnology Details
2.10.2 Shandong Huaan Biotechnology Major Business
2.10.3 Shandong Huaan Biotechnology Rapamycin Target Eluting Stent System Product and Services
2.10.4 Shandong Huaan Biotechnology Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Shandong Huaan Biotechnology Recent Developments/Updates
2.11 Shanghai Bioheart Biological Technology
2.11.1 Shanghai Bioheart Biological Technology Details
2.11.2 Shanghai Bioheart Biological Technology Major Business
2.11.3 Shanghai Bioheart Biological Technology Rapamycin Target Eluting Stent System Product and Services
2.11.4 Shanghai Bioheart Biological Technology Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Shanghai Bioheart Biological Technology Recent Developments/Updates
2.12 JW Medical Systems
2.12.1 JW Medical Systems Details
2.12.2 JW Medical Systems Major Business
2.12.3 JW Medical Systems Rapamycin Target Eluting Stent System Product and Services
2.12.4 JW Medical Systems Rapamycin Target Eluting Stent System Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 JW Medical Systems Recent Developments/Updates
3 Competitive Environment: Rapamycin Target Eluting Stent System by Manufacturer
3.1 Global Rapamycin Target Eluting Stent System Sales Quantity by Manufacturer (2018-2023)
3.2 Global Rapamycin Target Eluting Stent System Revenue by Manufacturer (2018-2023)
3.3 Global Rapamycin Target Eluting Stent System Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Rapamycin Target Eluting Stent System by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Rapamycin Target Eluting Stent System Manufacturer Market Share in 2022
3.4.2 Top 6 Rapamycin Target Eluting Stent System Manufacturer Market Share in 2022
3.5 Rapamycin Target Eluting Stent System Market: Overall Company Footprint Analysis
3.5.1 Rapamycin Target Eluting Stent System Market: Region Footprint
3.5.2 Rapamycin Target Eluting Stent System Market: Company Product Type Footprint
3.5.3 Rapamycin Target Eluting Stent System Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Rapamycin Target Eluting Stent System Market Size by Region
4.1.1 Global Rapamycin Target Eluting Stent System Sales Quantity by Region (2018-2029)
4.1.2 Global Rapamycin Target Eluting Stent System Consumption Value by Region (2018-2029)
4.1.3 Global Rapamycin Target Eluting Stent System Average Price by Region (2018-2029)
4.2 North America Rapamycin Target Eluting Stent System Consumption Value (2018-2029)
4.3 Europe Rapamycin Target Eluting Stent System Consumption Value (2018-2029)
4.4 Asia-Pacific Rapamycin Target Eluting Stent System Consumption Value (2018-2029)
4.5 South America Rapamycin Target Eluting Stent System Consumption Value (2018-2029)
4.6 Middle East and Africa Rapamycin Target Eluting Stent System Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2029)
5.2 Global Rapamycin Target Eluting Stent System Consumption Value by Type (2018-2029)
5.3 Global Rapamycin Target Eluting Stent System Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2029)
6.2 Global Rapamycin Target Eluting Stent System Consumption Value by Application (2018-2029)
6.3 Global Rapamycin Target Eluting Stent System Average Price by Application (2018-2029)
7 North America
7.1 North America Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2029)
7.2 North America Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2029)
7.3 North America Rapamycin Target Eluting Stent System Market Size by Country
7.3.1 North America Rapamycin Target Eluting Stent System Sales Quantity by Country (2018-2029)
7.3.2 North America Rapamycin Target Eluting Stent System Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2029)
8.2 Europe Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2029)
8.3 Europe Rapamycin Target Eluting Stent System Market Size by Country
8.3.1 Europe Rapamycin Target Eluting Stent System Sales Quantity by Country (2018-2029)
8.3.2 Europe Rapamycin Target Eluting Stent System Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Rapamycin Target Eluting Stent System Market Size by Region
9.3.1 Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Rapamycin Target Eluting Stent System Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2029)
10.2 South America Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2029)
10.3 South America Rapamycin Target Eluting Stent System Market Size by Country
10.3.1 South America Rapamycin Target Eluting Stent System Sales Quantity by Country (2018-2029)
10.3.2 South America Rapamycin Target Eluting Stent System Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Rapamycin Target Eluting Stent System Market Size by Country
11.3.1 Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Rapamycin Target Eluting Stent System Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Rapamycin Target Eluting Stent System Market Drivers
12.2 Rapamycin Target Eluting Stent System Market Restraints
12.3 Rapamycin Target Eluting Stent System Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Rapamycin Target Eluting Stent System and Key Manufacturers
13.2 Manufacturing Costs Percentage of Rapamycin Target Eluting Stent System
13.3 Rapamycin Target Eluting Stent System Production Process
13.4 Rapamycin Target Eluting Stent System Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Rapamycin Target Eluting Stent System Typical Distributors
14.3 Rapamycin Target Eluting Stent System Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table 1. Global Rapamycin Target Eluting Stent System Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Rapamycin Target Eluting Stent System Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Terumo Basic Information, Manufacturing Base and Competitors
Table 4. Terumo Major Business
Table 5. Terumo Rapamycin Target Eluting Stent System Product and Services
Table 6. Terumo Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Terumo Recent Developments/Updates
Table 8. QualiMe Basic Information, Manufacturing Base and Competitors
Table 9. QualiMe Major Business
Table 10. QualiMe Rapamycin Target Eluting Stent System Product and Services
Table 11. QualiMe Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. QualiMe Recent Developments/Updates
Table 13. Concept Medical Basic Information, Manufacturing Base and Competitors
Table 14. Concept Medical Major Business
Table 15. Concept Medical Rapamycin Target Eluting Stent System Product and Services
Table 16. Concept Medical Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Concept Medical Recent Developments/Updates
Table 18. USM Healthcare Basic Information, Manufacturing Base and Competitors
Table 19. USM Healthcare Major Business
Table 20. USM Healthcare Rapamycin Target Eluting Stent System Product and Services
Table 21. USM Healthcare Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. USM Healthcare Recent Developments/Updates
Table 23. Qmedics AG Basic Information, Manufacturing Base and Competitors
Table 24. Qmedics AG Major Business
Table 25. Qmedics AG Rapamycin Target Eluting Stent System Product and Services
Table 26. Qmedics AG Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Qmedics AG Recent Developments/Updates
Table 28. Cardionovum Basic Information, Manufacturing Base and Competitors
Table 29. Cardionovum Major Business
Table 30. Cardionovum Rapamycin Target Eluting Stent System Product and Services
Table 31. Cardionovum Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Cardionovum Recent Developments/Updates
Table 33. MicroPort Scientific Basic Information, Manufacturing Base and Competitors
Table 34. MicroPort Scientific Major Business
Table 35. MicroPort Scientific Rapamycin Target Eluting Stent System Product and Services
Table 36. MicroPort Scientific Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. MicroPort Scientific Recent Developments/Updates
Table 38. Lepu Medical Technology Basic Information, Manufacturing Base and Competitors
Table 39. Lepu Medical Technology Major Business
Table 40. Lepu Medical Technology Rapamycin Target Eluting Stent System Product and Services
Table 41. Lepu Medical Technology Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Lepu Medical Technology Recent Developments/Updates
Table 43. Medfavour Medical Basic Information, Manufacturing Base and Competitors
Table 44. Medfavour Medical Major Business
Table 45. Medfavour Medical Rapamycin Target Eluting Stent System Product and Services
Table 46. Medfavour Medical Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Medfavour Medical Recent Developments/Updates
Table 48. Shandong Huaan Biotechnology Basic Information, Manufacturing Base and Competitors
Table 49. Shandong Huaan Biotechnology Major Business
Table 50. Shandong Huaan Biotechnology Rapamycin Target Eluting Stent System Product and Services
Table 51. Shandong Huaan Biotechnology Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Shandong Huaan Biotechnology Recent Developments/Updates
Table 53. Shanghai Bioheart Biological Technology Basic Information, Manufacturing Base and Competitors
Table 54. Shanghai Bioheart Biological Technology Major Business
Table 55. Shanghai Bioheart Biological Technology Rapamycin Target Eluting Stent System Product and Services
Table 56. Shanghai Bioheart Biological Technology Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Shanghai Bioheart Biological Technology Recent Developments/Updates
Table 58. JW Medical Systems Basic Information, Manufacturing Base and Competitors
Table 59. JW Medical Systems Major Business
Table 60. JW Medical Systems Rapamycin Target Eluting Stent System Product and Services
Table 61. JW Medical Systems Rapamycin Target Eluting Stent System Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. JW Medical Systems Recent Developments/Updates
Table 63. Global Rapamycin Target Eluting Stent System Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Rapamycin Target Eluting Stent System Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Rapamycin Target Eluting Stent System Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 66. Market Position of Manufacturers in Rapamycin Target Eluting Stent System, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Rapamycin Target Eluting Stent System Production Site of Key Manufacturer
Table 68. Rapamycin Target Eluting Stent System Market: Company Product Type Footprint
Table 69. Rapamycin Target Eluting Stent System Market: Company Product Application Footprint
Table 70. Rapamycin Target Eluting Stent System New Market Entrants and Barriers to Market Entry
Table 71. Rapamycin Target Eluting Stent System Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Rapamycin Target Eluting Stent System Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Rapamycin Target Eluting Stent System Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Rapamycin Target Eluting Stent System Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Rapamycin Target Eluting Stent System Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Rapamycin Target Eluting Stent System Average Price by Region (2018-2023) & (US$/Unit)
Table 77. Global Rapamycin Target Eluting Stent System Average Price by Region (2024-2029) & (US$/Unit)
Table 78. Global Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Rapamycin Target Eluting Stent System Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Rapamycin Target Eluting Stent System Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Rapamycin Target Eluting Stent System Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Rapamycin Target Eluting Stent System Average Price by Type (2018-2023) & (US$/Unit)
Table 83. Global Rapamycin Target Eluting Stent System Average Price by Type (2024-2029) & (US$/Unit)
Table 84. Global Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Rapamycin Target Eluting Stent System Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Rapamycin Target Eluting Stent System Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Rapamycin Target Eluting Stent System Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Rapamycin Target Eluting Stent System Average Price by Application (2018-2023) & (US$/Unit)
Table 89. Global Rapamycin Target Eluting Stent System Average Price by Application (2024-2029) & (US$/Unit)
Table 90. North America Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Rapamycin Target Eluting Stent System Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Rapamycin Target Eluting Stent System Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Rapamycin Target Eluting Stent System Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Rapamycin Target Eluting Stent System Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Rapamycin Target Eluting Stent System Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Rapamycin Target Eluting Stent System Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Rapamycin Target Eluting Stent System Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Rapamycin Target Eluting Stent System Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Rapamycin Target Eluting Stent System Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Rapamycin Target Eluting Stent System Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Rapamycin Target Eluting Stent System Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Rapamycin Target Eluting Stent System Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Rapamycin Target Eluting Stent System Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Rapamycin Target Eluting Stent System Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Rapamycin Target Eluting Stent System Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Rapamycin Target Eluting Stent System Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Rapamycin Target Eluting Stent System Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Rapamycin Target Eluting Stent System Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Rapamycin Target Eluting Stent System Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Rapamycin Target Eluting Stent System Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Rapamycin Target Eluting Stent System Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Rapamycin Target Eluting Stent System Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Rapamycin Target Eluting Stent System Raw Material
Table 131. Key Manufacturers of Rapamycin Target Eluting Stent System Raw Materials
Table 132. Rapamycin Target Eluting Stent System Typical Distributors
Table 133. Rapamycin Target Eluting Stent System Typical Customers
List of Figures
Figure 1. Rapamycin Target Eluting Stent System Picture
Figure 2. Global Rapamycin Target Eluting Stent System Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Rapamycin Target Eluting Stent System Consumption Value Market Share by Type in 2022
Figure 4. Vertebral Artery Rapamycin Targeted Elution Stent System Examples
Figure 5. Coronary Rapamycin-Targeted Elution Stenting System Examples
Figure 6. Global Rapamycin Target Eluting Stent System Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Rapamycin Target Eluting Stent System Consumption Value Market Share by Application in 2022
Figure 8. Hospital Examples
Figure 9. Ambulatory Surgery Center Examples
Figure 10. Others Examples
Figure 11. Global Rapamycin Target Eluting Stent System Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Rapamycin Target Eluting Stent System Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Rapamycin Target Eluting Stent System Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Rapamycin Target Eluting Stent System Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Rapamycin Target Eluting Stent System Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Rapamycin Target Eluting Stent System Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Rapamycin Target Eluting Stent System by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Rapamycin Target Eluting Stent System Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Rapamycin Target Eluting Stent System Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Rapamycin Target Eluting Stent System Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Rapamycin Target Eluting Stent System Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Rapamycin Target Eluting Stent System Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Rapamycin Target Eluting Stent System Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Rapamycin Target Eluting Stent System Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Rapamycin Target Eluting Stent System Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Rapamycin Target Eluting Stent System Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Rapamycin Target Eluting Stent System Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Rapamycin Target Eluting Stent System Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Rapamycin Target Eluting Stent System Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Rapamycin Target Eluting Stent System Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Rapamycin Target Eluting Stent System Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Rapamycin Target Eluting Stent System Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Rapamycin Target Eluting Stent System Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Rapamycin Target Eluting Stent System Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Rapamycin Target Eluting Stent System Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Rapamycin Target Eluting Stent System Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Rapamycin Target Eluting Stent System Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Rapamycin Target Eluting Stent System Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Rapamycin Target Eluting Stent System Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Rapamycin Target Eluting Stent System Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Rapamycin Target Eluting Stent System Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Rapamycin Target Eluting Stent System Consumption Value Market Share by Region (2018-2029)
Figure 53. China Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Rapamycin Target Eluting Stent System Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Rapamycin Target Eluting Stent System Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Rapamycin Target Eluting Stent System Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Rapamycin Target Eluting Stent System Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Rapamycin Target Eluting Stent System Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Rapamycin Target Eluting Stent System Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Rapamycin Target Eluting Stent System Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Rapamycin Target Eluting Stent System Market Drivers
Figure 74. Rapamycin Target Eluting Stent System Market Restraints
Figure 75. Rapamycin Target Eluting Stent System Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Rapamycin Target Eluting Stent System in 2022
Figure 78. Manufacturing Process Analysis of Rapamycin Target Eluting Stent System
Figure 79. Rapamycin Target Eluting Stent System Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source